LIGHTHOUSE BIOTECH SRL
LIQUID BIOPSY using disposable microfluidics to detect, take image, sort of Circulating Tumor Cells based on metabolism
LIQUID BIOPSY using disposable microfluidics to detect, take image, sort of Circulating Tumor Cells based on metabolism
Lighthouse Biotech SRL is a biotechnology startup based in Italy that has caught the attention of investors with its innovative liquid biopsy technology. The company's slogan, "Liquid Biopsy using disposable microfluidics to detect, take image, sort of Circulating Tumor Cells based on metabolism," encapsulates its core focus. Lighthouse Biotech SRL's proprietary patented technology utilizes disposable microfluidics for the detection, imaging, sorting, and storage of single circulating tumor cells (CTCs) based on their abnormal metabolism. This unique approach enables the delivery of CTCs in native conditions, allowing for further analysis, such as DNA testing or biobanking, thereby bolstering cancer research and drug development. Founded in 2019, the company has received a seed round investment on 29 December 2021 from Utopia SIS SpA and Pariter Partners. This investment underscores the confidence that investors have in Lighthouse Biotech SRL's potential to drive key decisions in cancer treatment through its groundbreaking technology. As the company continues to make strides in the life sciences sector, it is poised to make a significant impact in the field of cancer diagnostics and treatment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 2 |
|
29 Dec 2021 |
No recent news or press coverage available for LIGHTHOUSE BIOTECH SRL.
We care about your data, and we'd love to use cookies make your experience better.